North America Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product type( Liposomal Doxurubicin, Liposomal Paclitxel, Liposomal Amphotericin B, Others); Technology( Stealth Liposome Technology, Non PEGylated Liposome Technology, Depofoam Liposome technology, Lysolipid thermally Sensitive Liposome Technology); Application( Fungal Diseases, Cancer Therapy, Pain management, Viral Vaccine); and Country

TIPRE00014203 | Pages: 138 | Pharmaceuticals | Sep 2020 | Type: Regional | Status: Published

Market Introduction

The Liposome are novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.


Get more information on this report :



Market Overview and Dynamics

The North America Liposome Drug Delivery market is expected to reach US$ 2735.64million by 2027 from US$ 1390.53 million in 2019. The market is anticipated to grow with a CAGR of 9.0 % from 2019 to 2027. Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.

Key Market Segments

In The liposome drug delivery market is mainly segmented on the basis of products, technology and applications. The products are liposomal doxorubicin, liposomal Paclitaxel.  On basis of technology it is segmented as stealth liposome technology, Depofoam liposome technology and others. And the final segmentation is on the application such as its usage in cancer therapy, fungal diseases, and pain management.

Major Sources and Companies Listed

Some of the major primary and secondary sources for Liposome drug delivery market included in the report are Food and Drug Administration (FDA), World health Organization (WHO) and others.

Reasons to buy the report

  • To understand the liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for liposome drug delivery market
  • Efficiently plan M&A and partnership deals in liposome drug delivery market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form liposome drug delivery market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region

NORTH AMERICA LIPOSOME DRUG DELIVERY MARKET SEGMENTATION

By Product

  • Liposomal doxurubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Others

 

By technology

  • Stealth liposome technology
  • Depofoam liposome technology
  • Non-PEGylated liposome Technology
  • Lysolipid thermally Sensitive Liposome Technology

 

By Application

•            Fungal diseases

  • Cancer therapy
  • Pain management
  • Viral vaccines
  • Photodynamic Therapy

 

Company Profiles

  • Takeda pharmaceutical company
  • Novartis AG
  • Ipsen pharma
  • Celsion Inc
  • Luye pharma group

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Liposome Drug Delivery Market – By Product

1.3.2        North America Liposome Drug Delivery Market – By Technology

1.3.3        North America Liposome Drug Delivery Market – By Application

1.3.4        North America Liposome Drug Delivery Market – By Geography

2.          North America Liposome Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Liposome Drug Delivery Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Liposome Drug Delivery Market - North America PEST Analysis

4.3        Expert Opinion

5.          North America Liposome Drug Delivery Market - Key Market Dynamics

5.1        Market Drivers

5.1.1        Rising prevalence of Chronic Diseases

5.1.2        Growing Demand for Non-Invasive Drug Delivery Devices

5.1.3        Increasing R&D Expenditures in Pharmaceutical Companies

5.2        Market Restraints

5.2.1        High Cost Involved in Development of Drug Delivery Systems

5.3        Market Opportunities

5.3.1        Development of New Lipid Composition for Stability and Optimization of Drugs

5.4        Future Trends

5.4.1        Increasing Popularity of Liposomes in Drug Delivery

5.5        Impact Analysis

6.          Liposome Drug Delivery Market – North America Analysis

6.1        North America Liposome Drug Delivery Market Revenue Forecasts and Analysis

7.          North America Liposome Drug Delivery Market Analysis and Forecasts To 2027 – By Product Overview

7.1        North America Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)

7.1.1        North America Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.2        Liposomal Doxurubicin

7.2.1        Overview

7.2.2        North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.3        Liposomal Paclitaxel

7.3.1        North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)

7.4        Liposomal Amphotericin B

7.4.1        overview

7.4.2        North America Liposomal Amphotericin B forecast and market revenue

7.5        Others

7.5.1        overview

7.5.2        North America Other Liposome Drug Delivery Market overview and forecast to 2027

8.          North America Liposome Drug Delivery Market – By Technology

8.1        Overview

8.2        North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

8.3        Stealth Liposome Technology

8.3.1        Overview

8.3.2        North America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Non-PEGylated Liposome Technology

8.4.1        Overview

8.4.2        North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.5        DepoFoam Liposome Technology

8.5.1        Overview

8.5.2        North America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.6        Lysolipid Thermally Sensitive Liposome (LTSL) Technology

8.6.1        Overview

8.6.2        North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.          North America Liposome Drug Delivery Market – By Application

9.1        Overview

9.2        North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

9.3        Fungal Diseases

9.3.1        Overview

9.3.2        Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4        Cancer Therapy

9.4.1        Overview

9.4.2        Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5        Pain Management

9.5.1        Overview

9.5.2        Pain Management: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.6        Viral Vaccine

9.6.1        Overview

9.6.2        Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.7        Photodynamic Therapy

9.7.1        Overview

9.7.2        Photodynamic Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.       North America Liposome Drug Delivery Market – Geographic Analysis

10.1     North America: Liposome Drug Delivery Market

10.1.1     Overview

10.1.2     North America: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4     North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.5     North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.6     North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

10.1.7     US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       US: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8     Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9     Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.       Impact Of COVID-19 Pandemic On North America Liposome Drug Delivery Market

11.1     North America: Impact Assessment of COVID-19 Pandemic

12.       Company Profiles

12.1     Takeda Pharmaceutical Company Limited

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.3     Novartis AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.5     Luye Pharma Group

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6     Johnson & Johnson Services, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7     Ipsen Pharma

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.       Appendix

13.1     About the Insight Partners

13.2     Word Index

LIST OF TABLES

Table 1.            R&D Investments by major pharmaceutical companies

Table 2.            North America Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 3.            North America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.            North America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 5.            North America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.            US Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.            US Skin aesthetic devices market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 8.            US Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.            Canada Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 10.         Canada Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 11.         Canada Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.         Mexico Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 13.         Mexico Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 14.         Mexico Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.         List of Abbreviation

LIST OF FIGURES

Figure 1.          Liposome Drug Delivery Market Segmentation

Figure 2.          North America Liposome Drug Delivery Segmentation : By Region

Figure 3.          North America Liposome Drug Delivery Market Overview;

Figure 4.          Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market

Figure 5.          US is Expected to Show Remarkable Growth During the Forecast Period.

Figure 6.          Liposome Drug Delivery Market - North America PEST Analysis

Figure 7.          North America Liposome Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 8.          North America Liposome Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          North America Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)

Figure 10.        North America Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        North America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        North America Liposomal Amphotericin B market revenue and forecast to 2027

Figure 13.        North America Other Liposome Drug Delivery Market overview and forecast to 2027

Figure 14.        North America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

Figure 15.        North America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        North America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        North America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        North America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        North America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

Figure 20.        Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Pain Management: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Photodynamic Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        North America: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

Figure 26.        North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

Figure 27.        North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

Figure 28.        US: Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Canada: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Mexico: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Impact of COVID-19 Pandemic In North American Country Markets

 

The List of Companies - North America Liposome Drug Delivery Market

  1. Takeda pharmaceutical company
  2. Novartis AG
  3. Ipsen pharma
  4. Celsion Inc
  5. Luye pharma group
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Liposome Drug Delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Liposome drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000